Skip to main content
. 2018 Oct 21;8(10):e022876. doi: 10.1136/bmjopen-2018-022876

Table 2.

Prevalence of PIPc by commission

Indicator No of children with at least one PIP No of eligible children Children prescribed at least one PIP (%) 95% CI
Carbocisteine should not be prescribed to children 13 546 414 856 3.27 3.21 to 3.32
Intranasal beclometasone should not be prescribed to children under 6 years of age 358 144 161 0.25 0.22 to 0.27
Sedating antihistamines should not be prescribed to children under 2 years of age 86 46 437 0.19 0.15 to 0.22
Codeine/dihydrocodeine medications should not be prescribed to children under 12 years of age 414 312 571 0.13 0.12 to 0.15
Loperamide should not be prescribed to children under 4 years of age 89 92 874 0.10 0.08 to 0.11
Tetracyclines should not be prescribed to children under 12 years of age 182 312 571 0.06 0.05 to 0.07
Domperidone should not be prescribed concomitantly with erythromycin 86 414 856 0.02 0.02 to 0.03

PIP, potentially inappropriate prescribing; PIPc, PIP in children.